Lee-Hwei King Sun is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of biopharmaceuticals, holding a total of 8 patents. His work focuses on developing innovative therapies that enhance patient safety and treatment efficacy.

Latest Patents

Among his latest patents is the invention of humanized anti-TNFα antibodies. This invention provides a humanized anti-TNF monoclonal antibody that significantly reduces the immunogenicity of murine antibodies while retaining the ability to recognize antigens. This advancement improves the safety of the antibody in clinical applications. Another notable patent involves Fc fusion proteins of human growth hormone. These fusion proteins exhibit good biological activities relative to recombinant human growth hormone (rhGH) on a molar basis. The hGH-L-vFc fusion protein comprises hGH, a flexible peptide linker, and a human IgG Fc variant, which minimizes undesirable side effects. This innovation leads to improved pharmacokinetics and pharmacodynamics, resulting in fewer injections needed over time.

Career Highlights

Lee-Hwei King Sun has worked with various companies, including Livzon Mabpharm Inc. His career is marked by a commitment to advancing biopharmaceutical technologies that address critical health challenges.

Collaborations

He has collaborated with notable individuals such as Bill N C Sun and Cecily R Y Sun, contributing to a dynamic research environment that fosters innovation.

Conclusion

Lee-Hwei King Sun's contributions to biopharmaceuticals through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact the development of safer and more effective therapies for patients.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com